182 related articles for article (PubMed ID: 10834181)
21. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
Quinn RR; Naimark DM; Oliver MJ; Bayoumi AM
Am J Kidney Dis; 2007 Sep; 50(3):421-32. PubMed ID: 17720521
[TBL] [Abstract][Full Text] [Related]
22. Stroke prevention in elderly patients with atrial fibrillation.
Lew SJ; Lim JK
Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
[TBL] [Abstract][Full Text] [Related]
23. Aspirin for atrial fibrillation.
Douglas M; Strelnick A
J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
[No Abstract] [Full Text] [Related]
24. Prevalence of inappropriate use of digoxin in 136 patients on digoxin and prevalence of use of warfarin or aspirin in 89 patients with persistent or paroxysmal atrial fibrillation.
Lleva P; Aronow WS; Gutwein AH
Am J Ther; 2009; 16(6):e41-3. PubMed ID: 19940604
[TBL] [Abstract][Full Text] [Related]
25. Atrial fibrillation and anticoagulation.
Garnier LF; Rouesnel P; Espitalier F
Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
28. [Comparative study of warfarin and aspirin for stroke prevention in elderly patients with atrial fibrillation].
Han W; Shen DT; Wang YM
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):851-2, 855. PubMed ID: 16793618
[TBL] [Abstract][Full Text] [Related]
29. Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial.
Hart RG; Bhatt DL; Hacke W; Fox KA; Hankey GJ; Berger PB; Hu T; Topol EJ;
Cerebrovasc Dis; 2008; 25(4):344-7. PubMed ID: 18303254
[TBL] [Abstract][Full Text] [Related]
30. [Factors associated to aspirin failure for secondary stroke prevention].
Chamorro A; Blanc R; Ascaso C; Saiz A; Vila N
Med Clin (Barc); 1997 Nov; 109(15):569-72. PubMed ID: 9441190
[TBL] [Abstract][Full Text] [Related]
31. Which parameters differ in very old patients with chronic atrial fibrillation treated by anticoagulant or aspirin? Antithrombotic treatment of atrial fibrillation in the elderly.
Doucet J; Gréboval-Furstenfeld E; Tavildari A; M'bello L; Delaunay O; Pesqué T; Moirot P; Mouton-Schleifer D
Fundam Clin Pharmacol; 2008 Oct; 22(5):569-74. PubMed ID: 18844728
[TBL] [Abstract][Full Text] [Related]
32. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
33. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
Petersen P; Kastrup J; Helweg-Larsen S; Boysen G; Godtfredsen J
Arch Intern Med; 1990 Apr; 150(4):819-21. PubMed ID: 2183733
[TBL] [Abstract][Full Text] [Related]
35. [Prevention of thromboembolism in patients with atrial fibrillation].
Veselka J; Bartůnĕk P
Vnitr Lek; 1996 Nov; 42(11):792-5. PubMed ID: 9012126
[TBL] [Abstract][Full Text] [Related]
36. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
[TBL] [Abstract][Full Text] [Related]
37. [Anticoagulation therapy in paroxysmal atrial fibrillation].
Risøe C; Gjesdal K
Tidsskr Nor Laegeforen; 2004 Apr; 124(7):950-2. PubMed ID: 15060644
[TBL] [Abstract][Full Text] [Related]
38. [Primary prevention of thrombosis for patients with atrial fibrillation].
Hori M
Rinsho Shinkeigaku; 2004 Nov; 44(11):752-5. PubMed ID: 15651282
[TBL] [Abstract][Full Text] [Related]
39. Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
Sam C; Massaro JM; D'Agostino RB; Levy D; Lambert JW; Wolf PA; Benjamin EJ;
Am J Cardiol; 2004 Oct; 94(7):947-51. PubMed ID: 15464686
[TBL] [Abstract][Full Text] [Related]
40. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
